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The Measles Virus Receptor SLAMF1 Can
Mediate Particle Endocytosis
Daniel Gonçalves-Carneiro,a Jane A. McKeating,a,b Dalan Baileya
Centre for Human Virology, Institute of Immunology and Immunotherapy, College of Medical and Dental
Sciences, University of Birmingham, Birmingham, United Kingdoma; Institute for Advanced Study, Technische
Universität München, Munich, Germanyb
ABSTRACT The signaling lymphocyte activation molecule F1 (SLAMF1) is both a mi-
crobial sensor and entry receptor for measles virus (MeV). Herein, we describe a new
role for SLAMF1 to mediate MeV endocytosis that is in contrast with the alternative,
and generally accepted, model that MeV genome enters cells only after fusion at the
cell surface. We demonstrated that MeV engagement of SLAMF1 induces dramatic but
transient morphological changes, most prominently in the formation of membrane
blebs, which were shown to colocalize with incoming viral particles, and rearrangement
of the actin cytoskeleton in infected cells. MeV infection was dependent on these dy-
namic cytoskeletal changes as well as ﬂuid uptake through a macropinocytosis-like
pathway as chemical inhibition of these processes inhibited entry. Moreover, we
identiﬁed a role for the RhoA-ROCK-myosin II signaling axis in this MeV internaliza-
tion process, highlighting a novel role for this recently characterized pathway in vi-
rus entry. Our study shows that MeV can hijack a microbial sensor normally involved
in bacterial phagocytosis to drive endocytosis using a complex pathway that shares
features with canonical viral macropinocytosis, phagocytosis, and mechanotransduc-
tion. This uptake pathway is speciﬁc to SLAMF1-positive cells and occurs within 60
min of viral attachment. Measles virus remains a signiﬁcant cause of mortality in hu-
man populations, and this research sheds new light on the very ﬁrst steps of infec-
tion of this important pathogen.
IMPORTANCE Measles is a signiﬁcant disease in humans and is estimated to have
killed over 200 million people since records began. According to current World Health
Organization statistics, it still kills over 100,000 people a year, mostly children in the
developing world. The causative agent, measles virus, is a small enveloped RNA virus
that infects a broad range of cells during infection. In particular, immune cells are
infected via interactions between glycoproteins found on the surface of the virus
and SLAMF1, the immune cell receptor. In this study, we have investigated the steps
governing entry of measles virus into SLAMF1-positive cells and identiﬁed endocytic
uptake of viral particles. This research will impact our understanding of morbillivirus-
related immunosuppression as well as the application of measles virus as an onco-
lytic therapeutic.
KEYWORDS SLAMF1, endocytosis, fusion, macropinocytosis, measles, morbillivirus,
virus attachment, virus entry
The signaling lymphocyte activation molecule family (SLAMF) comprises nine cellsurface-expressed glycoproteins that are involved in immune cell interactions and
belong to the immunoglobulin superfamily (1). In particular, SLAMF1 (also known as
CD150) is expressed on activated B and T lymphocytes as well as dendritic cells and
macrophages, and it has been implicated in lymphocyte development, thymocyte
maturation, and immunological synapse formation (2, 3). Of note, SLAMF1 was recently
reported to act as a microbial sensor and to regulate host immune responses to diverse
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bacteria (4). SLAMF1 binds outer membrane porins F and C, expressed by Gram-
negative bacteria, and stimulates the recruitment of autophagic components via a
beclin-1-, Vps34-, and Vps15-dependent pathway, leading to phagocytic killing of the
microbe (4).
In contrast to the antimicrobial function, SLAMF1 is the major entry receptor for
measles virus (MeV) (5). As recently as 1980, MeV was estimated to have caused 2.6
million deaths per year; however, routine vaccination has now brought this ﬁgure down
to 100,000. In humans, inhalation of virus-contaminated aerosols leads to MeV infection
of macrophages and dendritic cells within the lungs (6). Infection spreads to the local
lymph nodes, where a range of SLAMF1-expressing immune cells become infected. The
subsequent circulation of MeV-infected SLAMF1 cells in the periphery leads to infec-
tion of epithelial tissues in the respiratory tract, which facilitates transmission to new
hosts (6, 7). Infection of these epithelial cells is facilitated by a separate receptor,
nectin-4, a component of the adherens junction (8, 9). MeV spread from immune cells
to nectin-4-positive epithelia is dependent on cell-cell contact, consistent with the
highly cell-associated nature of MeV infection (10). As well as delivering MeV to sites for
onward transmission, infection of SLAMF1 lymphocytes and monocytes also contrib-
utes to the prolonged immunosuppression reported for infected subjects and may
explain their increased susceptibility to secondary bacterial infections.
MeV encodes two viral glycoproteins, the hemagglutinin (H) and fusion (F) proteins,
that mediate particle entry. Virus-associated H interacts with SLAMF1 and induces
conformational changes that activate F (11, 12) and prime fusion of the viral and host
cell membranes (13, 14). In addition, F and H induce the fusion of infected and naive
cells at neutral pH, leading to multinucleated cells or syncytia (15). This widely reported
phenomenon has led to the assumption that MeV enters cells only through direct
fusion with the cellular plasma membrane, with a limited requirement for particle
endocytosis (16); however, and importantly, there is no deﬁnitive study that demon-
strates that this phenomenon is the only mechanism for entry. Building on the
identiﬁcation of SLAMF1 as a sensor involved in bacterial phagocytosis along with
recent studies reporting on the endocytosis of related viruses, such as Ebola virus and
respiratory syncytial virus (RSV) (17, 18), we revisited the pathway of MeV entry. Herein,
we describe a novel internalization pathway for MeV to establish infection that is
dependent on its immune receptor, SLAMF1. Understanding the complex role of
SLAMF1-microbe interactions will impact our knowledge of innate immunity, immu-
nosuppression, and host-pathogen interactions.
RESULTS
MeV induces the formation of transient membrane structures. Internalization
pathways such as phagocytosis and macropinocytosis involve a rearrangement of the
plasma membrane (19), with membrane blebbing associated with the uptake of several
pathogens, such as Pseudomonas aeruginosa (20) and vaccinia virus (21). We studied
the effect of MeV interaction with a patient-derived B-lymphoblastoid cell line that
expresses SLAMF1 (6). These cells support MeV replication and generate substantial
levels of infectious progeny (Fig. 1A and B). To examine the response to infection,
B-lymphoblastoid cells were synchronously infected with puriﬁed MeV particles (the
cellular contaminants having been removed by sucrose gradient-based ultracen-
trifugation [Fig. 1C]), through initial adsorption at 4°C for 1 h. Particle purity was
assessed by silver staining and Western blotting of virus preparations (Fig. 1C). A
high multiplicity of infection (MOI) was used to identify and observe wholescale
physiological responses to infection by microscopy, in accordance with previous
studies (17). Unbound virus was removed by washing, and the cells were incubated
at 37°C for 20 min before examination by scanning electron microscopy (SEM) (Fig.
1D). Infected B-lymphoblastoid cells showed signiﬁcantly more membrane blebs than
uninfected cells (P  0.005; t test) (Fig. 1E, bottom graph); however, the frequency of
cells exhibiting membrane rufﬂes did not vary (Fig. 1E, top graph).
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FIG 1 MeV induces the formation of transient membrane structures in SLAMF1-positive lymphocytes. (A)
B-lymphoblastoid cells were inoculated with recombinant MeV (MOI, 0.1) engineered to express EGFP
and incubated for 72 h prior to visualization by UV phase-contrast microscopy at high and low
magniﬁcations (mag’). (B) B-lymphoblastoid cells were infected with MeV (MOI, 0.01) and incubated at
37°C prior to quantiﬁcation of viral progeny, by 50% tissue culture infective dose (TCID50), at the
indicated times. HPI, hours postinfection. (C) MeV was puriﬁed by ultracentrifugation using a stepped
sucrose gradient. The opalescent band located at 30-45% sucrose cushion interface was extracted
and dialyzed. Protein lysates from these puriﬁed virus preparations were analyzed by silver staining
and Western blot analysis. Mk, protein marker. (D) B-lymphoblastoid cells were synchronously
infected with MeV (MOI, 20) or mock infected with 20% FBS-containing DMEM before ﬁxation,
preparation, and visualization by SEM. (E) Images were blinded and representative micrographs
quantiﬁed for membrane blebs and membrane rufﬂes. Statistical analysis was performed using the
Student t test. ***, P  0.001. n.s., nonsigniﬁcant.
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To examine the SLAMF1 dependency and cell type speciﬁcity of MeV-induced
changes in cellular morphology, we generated human lung epithelial A549 cells stably
expressing SLAMF1 and demonstrated their ability to support infection with MeV (Fig.
2A) and lentiviral pseudotypes bearing MeV-encoded F and H (MeV-PP) (Fig. 2B), a tool
that allows speciﬁc and quantitative assessment of MeV entry (22). MeV induced a
signiﬁcant increase in membrane blebs within 20 min (Fig. 2C and D), and SEM of
infected SLAMF1 cells identiﬁed additional morphological changes, including extensive
ﬁlopodium formation on the cell surface (Fig. 2E, orange arrowheads) and cellular
contraction (Fig. 2F) compared to those of uninfected cells. Interestingly, infection-
induced blebbing (Fig. 2E, white arrowheads), ﬁlopodium formation, and contraction
were transient and resolved by 60 min postinfection (Fig. 2F). These data highlight a
conserved SLAMF1-dependent cellular response to MeV infection that exhibits hall-
marks of endocytic uptake.
MeV particles can be endocytosed. Although it is generally assumed that MeV can
fuse at the plasma membrane, the morphological response we observed following
infection of B-lymphoblastoid cells and A549-SLAM cells resembled membrane struc-
tures reported during macro- and phagocytosis (23), suggesting that MeV can also be
internalized. To investigate this further, we examined the sensitivity of virus-associated
H to digestion with trypsin (see schematic in Fig. 3A). We conﬁrmed the sensitivity of
MeV-associated glycoproteins to tryptic digestion (Fig. 3B). A549-SLAMF1 cells were
FIG 2 MeV infection of SLAMF1-recombinant A549 cells induces blebbing, ﬁlopodium formation, and cellular retraction. (A) A549 or
A549-SLAMF1 cells were infected with MeV (MOI, 1) and incubated for 48 h prior to cell lysis, clariﬁcation of supernatant, and
quantiﬁcation of viral progeny via TCID50 (n.d., not detected). (B) Similarly, A549 and A549-SLAMF1 cells were infected with MeV-PP
reporter virus and incubated for 72 h prior to lysis and measurement of luciferase activity. (C and D) A549-SLAM cells were serum
starved overnight and inoculated with MeV (MOI  45) for 1 h at 4°C. Cells were washed with PBS and incubated at 37°C for 30 min
before ﬁxation with 4% PFA and visualization by phase-contrast microscopy. Representative micrographs of infected and uninfected
cells are provided at a magniﬁcation of 40. (C) The percentage of cells that presented membrane blebs per ﬁeld of view was
calculated for both samples (D). (E and F) Similarly, serum-starved A549-SLAMF1 cells were synchronously infected with MeV (MOI 
30) and incubated at 37°C for 0, 10, 30 or 60 min postinfection (mpi) before ﬁxation and imaging by SEM. The cell surface of
uninfected and infected cells presented small ﬁlopodium-like structures at the surface (orange arrowheads), but only infected cells
presented membrane blebs (white arrowheads) (E). Infected A549-SLAMF1 cells retracted after infection, in association with these
membrane blebs; however, this was transient and lasted only 60 min (F). All statistical analysis was performed using the Student
t test. **, P  0.005; error bars indicate SDs.
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synchronously infected, through adsorption at 4°C for 1 h (puriﬁed MeV; MOI, 30),
washed, and incubated at 37°C for 0, 15, or 30 min prior to treatment with trypsin
(Fig. 3A). MeV H was detected in all nontrypsinized cells at its full-length size of 75 kDa
and was sensitive to trypsin cleavage both immediately after viral adsorption and 15
FIG 3 MeV particles are endocytosed. (A) Diagram of experimental setup. Puriﬁed MeV was attached to A549-SLAMF1
cells (MOI 30) at 4°C for 1 h, washed with PBS to remove unbound virus, and incubated for 0, 15, or 30 min at 37°C
prior to trypsin treatment. (B) MeV particles were incubated with trypsin at 37°C for 7 min prior to addition of an equal
volume of complete fetal calf serum (FCS)-containing cell culture medium. Lysates were generated with Laemmli
buffer and resolved on a 15% SDS-PAGE gel, followed by Western blotting with anti-MeV H antibody. (C) Total cell
lysates were generated and resolved on a 15% SDS-PAGE gel prior to Western blotting using a polyclonal antibody
raised against the cytoplasmic tail of MeV H. Three H-speciﬁc bands were detected with approximate sizes of 75 kDa
(black arrowhead; full length), 24 kDa (blue arrowhead), and 20 kDa (white arrowhead), the latter two detected only
after trypsin treatment. The data are representative of those from four individual experiments. Of note, the speciﬁcity
of this assay was preserved using an antibody speciﬁc to the intravirion tail of MeV H that allowed detection of
tryptically digested variants. (D) A549-SLAMF1 cells were synchronously infected with MeV (MOI, 1), incubated for
the indicated times (minutes postinfection), and trypsinized for 7 min at 37°C. Cells were pelleted, resuspended in
complete medium, and incubated for 48 h, and virus infectivity was determined (error bars indicate SDs). (E and F)
HEK293T-SLAMF1 cells carrying a split form of Renilla luciferase (RLuc1) were synchronously infected with puriﬁedMeV
(MOI  30) for 60 min at 4°C, washed with PBS, and incubated for 0, 15, 30 or 60 min postinfection (mpi), with or
without 5 g/ml of chlorpromazine (CPZ), an inhibitor of clathrin pit formation and membrane protein sequestration,
at 37°C prior to the addition of HEK293T-SLAMF1 cells expressing the complementary part of the luciferase (RLuc2).
Cells were cocultured for 90 min before addition of the luciferase substrate coelenterazine and measurement of light
in a luminometer. Values were normalized by subtracting the values from uninfected cells and plotted as relative light
units (error bars indicate standard errors). Statistical analysis was performed using the Student t test. **, P 0.005; ***,
P  0.001. n.s., nonsigniﬁcant.
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min later (Fig. 3C, blue and white arrowheads, i. Trypsin). However, when infected cells
were incubated at 37°C for longer periods nondigested H was detected, consistent with
particle internalization and protection from trypsin (Fig. 3C, black arrowhead, ii. Tryp-
sin). Accordingly, when virus yields from a similar experiment were assayed 48 h
postinfection to assess the fate of internalized virus, protection from trypsin equivalent
to that of untreated cells was seen (Fig. 3D). To validate these observations, we used an
adapted MeV cell-cell fusion assay (13) that relies on cell-bound virus-associated
glycoproteins to fuse neighboring cells (see schematic in Fig. 3E). This assay showed a
loss in MeV glycoprotein-dependent fusion over time, consistent with particle internal-
ization (Fig. 3F). Importantly, this process was not inhibited by chlorpromazine (CPZ), a
drug that blocks the formation of clathrin-coated pits, an important step in the
recycling of surface proteins that could feasibly take place after MeV entry at the
plasma membrane (Fig. 3F). Together, these data support a model of MeV internaliza-
tion and suggest multiple pathways for MeV to establish infection.
MeV internalization is independent of clathrin-, caveolin-, or Dyn2-mediated
endocytosis. To further examine the potential for MeV endocytosis, we employed a
quantitative particle entry assay based on reporter HIV-1 pseudotypes bearing MeV F
and H (MeV-PP) (22). MeV-PP entry into A549-SLAMF1 cells was not sensitive to green
ﬂuorescent protein (GFP)-tagged dominant negative (DN) mutant proteins involved in
clathrin-mediated endocytosis (epidermal growth factor receptor pathway substrate 15
[EPS15]), caveolin-mediated endocytosis (caveolin-1 [Cav-1]), or dynamin-dependent
endocytosis (dynamin-2 [Dyn2]) (Fig. 4A). In contrast, vesicular stomatitis virus glyco-
protein (VSV-G)-pseudotyped HIV-1 (VSV-PP), which is known to enter via clathrin-
mediated endocytosis, was sensitive to enhanced GFP (EGFP)-tagged DN EPS15 (Fig.
4A). In all instances, the efﬁcient expression of DN mutants was conﬁrmed through
observation of GFP expression. Similarly, chloroquine and baﬁlomycin A1, lysosomo-
tropic agents that inhibit endosomal acidiﬁcation and caveolin-dependent endocytosis,
respectively, had no effect on MeV-PP entry but reduced VSV-PP infection, as did the
dynamin-2 inhibitor dynasore (Fig. 4B). Collectively, these data show that MeV particle
internalization is independent of clathrin-, caveolin-, or dynamin-2-mediated endocytic
pathways.
MeV induces ﬂuid uptake in a SLAMF1-dependent manner. The internalization
of extracellular ﬂuid, assayed through uptake and concentration of cell-impermeative
ﬂuorescent dextran, is considered a benchmark for macropinocytosis (23). MeV (MOI,
FIG 4 MeV particles are internalized in a clathrin-, caveolin-, and dynamin-2-independent manner. (A)
A549-SLAMF1 cells were transfected with plasmids expressing dominant negative (DN) mutants of EPS15,
cav-1, and Dyn2 and 48 h posttransfection were transduced with MeV- or VSV-PPs. As a control, cells were
transfected with an empty plasmid (Vector). After 72 h, cells were lysed and luciferase activity was
measured. (B) A549-SLAMF1 cells were pretreated with chloroquine (CQ; 50 g/ml), baﬁlomycin A1 (BAF;
50 g/ml), dynasore (DYN; 100 M), or solvent for 30 min at 37°C. MeV- or VSV-PP encoding the ﬁreﬂy
luciferase reporter was added to cells and incubated for 3 h. Medium was replaced and cells were
incubated for 72 h before lysis, addition of the luciferase substrate luciferin, and measurement of
produced light. Statistical analysis was performed using the Student t test. *, P  0.05; **, P  0.005. n.s.,
nonsigniﬁcant (error bars indicate standard errors).
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10) and the macropinocytosis-inducing phorbol 12-myristate 13-acetate (PMA) in-
duce ﬂuid uptake and formation of ﬂuorescent dextran-positive vesicles in A549-
SLAMF1 and B-lymphoblastoid cells (Fig. 5A to D). Confocal scanning laser microscopy
(CSLM) imaging and quantiﬁcation of the punctate dextran signal in macropinosomes
FIG 5 MeV induces ﬂuid uptake in a SLAMF1-dependent manner. (A) A549-SLAMF1 cells were synchronously infected with MeV (MOI  10) for 1 h at 4°C,
washed in cold PBS, and incubated at 37°C for 20 min with DMEM containing 0.25 mg/ml of dextran-Alexa Fluor 488 conjugate. Alternatively, cells were treated
with a 200 nM concentration of the macropinocytosis inducer phorbol 12-myristate 13-acetate (PMA). Cells were moved to ice, washed, bleached, and ﬁxed
in 4% PFA. Samples were analyzed by CSLM. Representative micrographs of uninfected, MeV-infected, and PMA-treated cells were recorded. The bar represents
15 m. (B) Quantiﬁcation of internalized dextran (pseudocolored green) was performed by calculating corrected total cell ﬂuorescence based on mean
ﬂuorescence intensity (MFI). Statistical analysis was performed using the Student t test. *, P  0.05 (error bars indicate standard errors). (C) To assess the role
of SLAMF1 in ﬂuid uptake during MeV infection, A549 and A549-SLAMF1 cells were synchronously mock or MeV infected (MOI  10), incubated with
dextran-containing PBS for 30 min, ﬁxed, and analyzed by CSLM (left) with the mean ﬂuorescent intensity quantiﬁed and expressed relative to the background
(right). (D) B-lymphoblastoid cells (LCLs) were attached to a glass coverslip, synchronously infected with MeV (MOI, 20), and incubated with DMEM containing
0.25 mg/ml of dextran-Alexa Fluor 488 conjugate. Cells were moved to ice, washed, bleached, and ﬁxed before analysis by CSLM. The bar represents 5 m. (E)
A549-SLAMF1 cells were synchronously infected withMeV (MOI 10), washed and incubated at 37°C in dextran-containing PBS for the indicated times, ﬁxed, prepared,
and analyzed by CSLM. Dextran is showed in green, while MeV N is pseudocolored in red; arrowheads indicate colocalization of N and dextran-positive vesicles. (F)
Using a similar approach and CSLM analysis, the colocalization of MeV N puncta with dextran-containing endosomes was quantiﬁed at 0, 15, 30, 45, and 60 min
postinfection. Statistical analysis was performed using analysis of variance (ANOVA); F (4, 47; ratio variables obtained with a Brown-Forsythe test) 6.076; P 0.0005
(error bars indicate standard errors). (G) Intensity analysis was performed using Leiss ZEN software, by proﬁling of red and green channels along the indicated line.
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conﬁrmed that MeV induced a signiﬁcant increase in intracellular dextran (Fig. 5A and
B) that was, importantly, SLAMF1 dependent and not seen in nonpermissive parental
A549 cells (Fig. 5C) yet was seen in B-lymphoblastoid cells (Fig. 5D). Since we could
readily detect dextran-stained vesicles, we next investigated whether these macropi-
nosomes represent sites of internalized MeV. Indeed, we demonstrated that incoming
MeV colocalizes with dextran-positive macropinosomes (Fig. 5E). Quantiﬁcation of this
colocalization indicated that this was most prevalent between 30 and 45 min after
infection, concurrent with the wide-scale formation of dextran-positive puncta (Fig. 5F).
Computational analysis of the ﬂuorescent signals conﬁrmed the speciﬁcity of this
colocalization as well as the enlargement of dextran-positive macropinosomes (Fig. 5G).
Combined, these data suggest that MeV particle and ﬂuid uptake occur concurrently
after infection and that this process is SLAMF1 dependent.
MeV is sensitive to inhibition of macropinocytosis. The membrane rearrange-
ments that characterize macropinocytosis require activation of Rac1 and Cdc42 GTPases
to support cytoskeletal reorganization. The drug amiloride analogue 5-(N-ethyl-N-
isopropyl) amiloride (EIPA) reduces the submembranous pH, which is necessary for
Rac1 and Cdc42 activation, and blocks macropinocytic ﬂuid uptake (24). Treating
A549-SLAMF1 cells with EIPA reduces both MeV-PP entry (Fig. 6A) and the number of
infectious MeV foci formed (Fig. 6B). The speciﬁc macropinocytosis-inhibitory activity of
EIPA was conﬁrmed through targeted inhibition of PMA-induced dextran uptake in
A549-SLAMF1 cells (Fig. 6C). Transfecting A549-SLAMF1 cells with GFP-tagged DN
mutants of Rac1 and Cdc42 (N17) reduced MeV-PP entry (Fig. 6D). These constructs also
signiﬁcantly reduced MeV entry/infection (Fig. 6E). Interestingly, transient expression of
GFP-tagged constitutively active (CA) (L61 for Rac1 and Cdc42) variants of these
GTPases (Fig. 6D), as well as separate modulation of levels of p21-activated kinase-1
(PAK-1), a downstream effector of Rac1 and Cdc42 (23), using a CA mutant (Fig. 6F) or
small interfering RNA (siRNA) knockdown (Fig. 6G) had only modest effects on MeV
entry. These results show that although MeV entry is sensitive to EIPA, a traditional
inhibitor of macropinocytosis, it does not appear to absolutely depend on the activity
of Rac1 or Cdc42, especially since CA mutants were unable to boost entry. This
contrasts with traditional requirements for macropinocytosis, suggesting perhaps a
more complex entry pathway that may be speciﬁc to MeV-SLAMF1 interactions.
Role for the mechanotransduction RhoA-ROCK-myosin II axis in MeV infection.
Filopodia and blebbing are characteristic features of migrating cells that rely on a
dynamic actin cortex. Actomyosin contractility is regulated by intracellular signaling
referred to as mechanotransduction. One of the best-understood examples is the
ubiquitous RhoA-ROCKI-myosin II signaling axis, a feedback loop that responds to
changes in extracellular matrix to modulate cellular motility (25). Given our earlier
observations of MeV-induced changes in cellular morphology, we investigated a role
for the RhoA-ROCKI-myosin II signaling axis in MeV entry. MeV-PP (Fig. 7A) and MeV
(Fig. 7B) infection of A549-SLAMF1 cells was reduced by a DN variant (N19) of RhoA
(another GTPase), although the latter was not signiﬁcant. We attribute this muted
effect, in part, to a combination of poor transfection efﬁciency in A549-SLAMF1 cells
and the subsequent entry of MeV into nontransfected cells, where macropinocytosis
remains active. However, in agreement with our previous experiments with RacI and
Cdc42, the CA variant (L63) of RhoA had no signiﬁcant effect on entry of MeV-PP (Fig.
7A) or MeV (data not shown). Interestingly, though, targeting the ROCKI protein, which
acts downstream of RhoA to regulate myosin light chain phosphorylation, with the
speciﬁc inhibitor H-1152 did signiﬁcantly reduce MeV-PP entry (Fig. 7C). Nonetheless,
the most notable effect on MeV entry was seen when targeting the myosin II element
of the axis, a protein involved in the rapid contractility of the cortical actin network and
essential for bleb formation. The myosin II-speciﬁc inhibitor blebbistatin signiﬁcantly
inhibited infection by MeV-PP (Fig. 7D) and MeV (Fig. 7E) but not VSV-PP. The speciﬁc
inhibitory activity of blebbistatin was also conﬁrmed through targeted inhibition of
PMA-induced dextran uptake in A549-SLAMF1 cells (Fig. 7F). Blebbistatin was shown to
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inhibit MeV infection in a dose-dependent manner when target cells were treated
before but not after infection (Fig. 7G), conﬁrming a role for this compound in targeting
steps involved in MeV entry. In summary, these data show that MeV entry is sensitive
to perturbation of the mechanotransduction RhoA-ROCKI-myosin II axis and suggest a
role for SLAMF1 to regulate cell motility and macropinocytic-like processes that are
dependent on cytoskeletal reorganization.
MeV induces cytoskeletal reorganization in a SLAMF1-dependent manner. The
ﬂuid uptake, ﬁlopodium formation, and blebbing observed during MeV infection of
SLAMF1-positive cells are dependent on a highly dynamic actin cytoskeleton (23). Such
morphological changes are associated with cell contraction and are a characteristic
feature of macropinocytosis but not phagocytosis (23). Using phalloidin, a high-afﬁnity
probe for actin ﬁlaments, we demonstrated that MeV induces a transient cellular
FIG 6 MeV infection is inhibited by amiloride. (A) A549-SLAMF1 cells were treated with 25 M EIPA prior to infection with MeV- or VSV-PPs for
3 h SLAMF1 and incubation in complete medium. Luciferase activity was measured 72 h later. (B) A549-SLAMF1 cells were pretreated with EIPA
and infected with MeV (MOI  1) at the indicated concentrations, before trypsinization and culture at 37°C for an additional 6.5 h. Cells were
detached with 2 mM EDTA solution, and GFP ﬂuorescence was analyzed by ﬂow cytometry. (C) A549-SLAM cells were incubated with EIPA at the
indicated concentration for 30 min, washed, and incubated with 200 nM PMA in dextran-containing PBS for 30 min. Cells were then bleached,
washed, and prepared for CSLM. (D) A549-SLAMF1 cells were transfected with constructs encoding myc-tagged dominant negative (DN) mutants
(Rac1 N17 and Cdc42 N17) or GFP-tagged constitutively active (CA) forms (Rac1 L61 and Cdc42 L61) of the indicated RhoGTPases. Cells were then
infected with MeV-PP and luciferase activity was measured 72 h later. (E) Similarly, cells were transfected with the same constructs, infected with
MeV (MOI  1), and incubated for 24 h. Infected cells were quantiﬁed by UV microscopy. (F) Cells were transfected with plasmid constructs
encoding wild-type (WT) or a CA mutant of PAK-1 and infected with MeV-PP before quantiﬁcation by luciferase assay. (G) A549-SLAMF1 cells
were transfected with either random siRNA (control), siRNA targeting PAK-1, or a carrier. Seventy-two hours later, cells were infected with MeV
(MOI  1), incubated for 24 h, and lysed for Western blot analysis. In all instances the expression of DN, WT, or CA proteins was conﬁrmed by
Western blotting or ﬂuorescence microscopy (not shown). Statistical analysis was performed using the Student t test. *, P  0.05; **, P  0.005.
n.s., nonsigniﬁcant (error bars indicate SDs).
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retraction peaking at 20 min, in association with actin bundle formation (Fig. 8A, orange
arrowheads), before returning to baseline at 60 min postinfection (Fig. 8A). Quan-
tiﬁcation of cellular area after CSLM conﬁrmed this retraction (Fig. 8B). Importantly,
this retraction was not the result of incubating cells at 4°C (Fig. 8C) and, similar to
dextran uptake, was dependent on SLAMF1 expression, observed both by CSLM
(Fig. 8D) and through repeated quantiﬁcation of cell area (Fig. 8E). To understand
the role of these blebs in MeV internalization, we imaged particles and demon-
strated a colocalization with actin-enriched membrane structures (Fig. 8F, 30 min,
blue arrowheads). MeV particles were actin positive before internalization (Fig. 8F, 0
min), as previously reported (26). Again this association, together with the disruption of
the actin cytoskeleton, was transient (Fig. 8F, 60 min). These data demonstrate that the
contraction of the cell associates with virus-induced macropinocytic-like responses, i.e.,
blebbing, to facilitate viral entry in a receptor-dependent manner.
To examine the cellular response to this retraction, we focused on the ezrin-radixin-
moesin family of proteins (ERMs). ERMs cross-link actin ﬁlaments and the plasma
membrane and can regulate membrane blebbing; e.g., ezrin linkage inhibits blebbing
FIG 7 The RhoA-ROCK-myosin II axis is important for virus infection. (A) A549-SLAMF1 cells were transfected with constructs encoding
myc-tagged DN (Rho N19) or GFP-tagged CA (Rho L63) of RhoA. Cells were infected with MeV-PP, and luciferase activity was measured
72 h later. (B) Similarly, cells were transfected with the same constructs, infected with MeV (MOI  1), and incubated for 24 h; infected
cells were quantiﬁed under UV microscopy. (C) A549-SLAMF1 cells were pretreated with the ROCKI inhibitor H-1152 at the indicated
concentrations for 5 h before infection with MeV- or VSV-PP, and luciferase activity was measured 72 h later. (D) A549-SLAMF1 cells
were pretreated with blebbistatin (BLEB) or solvent for 30 min before infection with MeV- or VSV-PP for 3 h, unbound virus was
removed by washing, and cells were incubated for 72 h in complete medium prior to measurement of luciferase activity. (E) In a similar
experiment, cells were pretreated with 100 M BLEB for 30 min and infected with MeV (MOI  1) for 1 h. Cells were trypsinized and
incubated for 24 h before quantiﬁcation of the frequency of GFP cells and total yield of virus. (F) A549-SLAM cells were incubated
with blebbistatin at the indicated concentration for 30 min, washed, and incubated with 200 nM PMA in dextran-containing PBS for
30 min. Cells were then bleached, washed, and prepared for CSLM. Please refer to Fig. 6C for relevant control image. (G) To address
if blebbistatin had a dose-dependent effect on MeV entry, A549-SLAMF1 cells were either pre- or posttreated with the drug at the
indicated concentrations, trypsinized, and incubated at 37°C for 24 h. Total cell lysates were generated and resolved on a 15%
SDS-PAGE gel prior to Western blotting using a polyclonal antibody raised speciﬁcally for MeV H cytoplasmic tail. Statistical analysis
was performed using the Student t test. *, P  0.05; **, P  0.005. n.s., nonsigniﬁcant (error bars indicate SDs).
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FIG 8 MeV induces cytoskeleton reorganization in a SLAMF1-dependent manner. (A and C) A549-SLAMF1 cells were synchronously
infected with MeV (MOI,15) for 1 h at 4°C (A) or incubated with 20% FBS-DMEM under the same conditions (No virus) (C). Cells were
washed in cold PBS and incubated at 37°C for 0, 10, 20, or 60 min prior to ﬁxation with 4% PFA, staining with phalloidin-TRITC
(pseudocolored in white), and analysis by CSLM. Orange arrowheads indicate actin-enriched domains. (B) The average cell area (in pixel
units) of individual cells was calculated based on representative micrographs of each condition using ImageJ. Statistical analysis was
performed using the Student t test. *, P  0.05 (error bars indicate SDs). (D) To assess the role of SLAMF1 in inducing the contraction
of the cytoskeleton during MeV infection, A549 and A549-SLAMF1 cells were synchronously mock or MeV infected (MOI  10),
incubated at 37°C for 30 min, ﬁxed, and analyzed by CSLM. The bar represents 30 m. (E) Six representative micrographs of each
condition were analyzed, and the average cell area was calculated. Statistical analysis was performed using a one-tailed Student t test.
*, P  0.05 (error bars indicate SDs). (F) A549-SLAMF1 cells were synchronously infected with MeV (MOI  15), incubated at 37°C for
0, 15, 30, or 60 min, ﬁxed, and prepared for CSLM. Blue arrowheads represent MeV N (in red) and actin (white) colocalization. (G)
A549-SLAMF1 cells were synchronously infected with MeV (MOI,15), washed, and incubated at 37°C for 0, 10, 20, 30, or 45 min prior
to lysis and ERM phosphorylation analysis by SDS-PAGE and Western blotting. (H) A549-SLAMF1 cells were pre- or posttreated with the
indicated concentrations of cytochalasin D (CytoD) or jasplakinolide (Jasp) and infected with MeV (MOI  1). Total cell lysates were
generated 24 h postinfection and resolved on a 15% SDS-PAGE gel prior to Western blotting using a polyclonal antibody raised against
the cytoplasmic tail of MeV H.
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through formation of the rigid uropod during directional migration (27). MeV infection
of A549-SLAMF1 cells induced ERM phosphorylation within 10 min (Fig. 8G), and this was
sustained for the duration of morphological changes, indicative of a cellular response to
stabilize membrane-cytoskeleton interactions. To examine in detail whether a respon-
sive and dynamic actin network is required for MeV entry, we used a panel of
well-characterized chemical inhibitors. MeV infection was sensitive to both inhibition
(cytochalasin D) and promotion (jasplakinolide) of actin polymerization (Fig. 8H) as well
as inhibitors of the Arp2/3 complex (CK-666) and Wiskott-Aldrich syndrome protein
(WASP; wiskostatin) (data not shown). Together, these results demonstrate that MeV-
induced reorganization of the cytoskeleton, particularly the cortical actin network, is
essential for infection and is regulated by ERM phosphorylation.
DISCUSSION
Until recently, paramyxovirus and pneumovirus genome entry into the cell was
assumed to occur only at the cell surface after fusion of particle-associated glycopro-
teins with the plasma membrane and without the need for virus internalization (16, 28).
The piece of data supporting this model is that triggering of many of their viral fusion
proteins is pH independent, e.g., MeV F (29, 30). However, recent studies on entry of
viruses with pH-neutral modes of fusion, e.g., RSV, Newcastle disease virus, Sendai virus,
and Nipah virus, have demonstrated virions being endocytosed (17, 28, 31). Our data
clearly show that MeV particles can internalize in a SLAMF1-dependent manner (Fig. 9).
We propose that activation of the F protein is initiated at the cell surface and that this
can prime either fusion and uncoating at the plasma membrane or an endocytic step
involving particle internalization and concurrent genome escape. We believe that the
pathway for MeV genome entry may therefore be determined by the valence of
interactions between a virus particle and a host cell. When considering the factors
involved in stimulating SLAMF1-dependent endocytic uptake, it is important to con-
FIG 9 Model of endocytic MeV entry into SLAMF1-positive cells. (A) MeV binds to human SLAMF1 (CD150) via a speciﬁc protein-protein interaction
between the viral hemagglutinin and SLAMF1. (B) Within 10 min, the receptor interaction induces the formation of membrane blebs, governed
in part by the RhoA-ROCK-myosin II axis. Inhibition of this axis (with chemical inhibitors or dominant negative mutants) reduces MeV entry. (C)
The formation of membranous blebs is followed by an acute retraction of the cell, orchestrated by the cortical cytoskeleton. Perturbation of this
process with chemical inhibitors of actin modulation also reduces MeV entry. (D) The internalization of MeV particles is concurrent with ﬂuid
uptake via a macropinocytosis-like pathway, a process that is sensitive to chemical inhibition with EIPA. Within 45 min, infected cells begin to
reestablish their characteristic morphology through speciﬁc phosphorylation of ERM proteins.
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sider differences in the activity of non-particle-associated F-H complexes and the MeV
particle itself, which is large (up to 1 m), pleomorphic, and densely packed with viral
glycoproteins. These may directly affect the interactions between the particle and the cell
and, moreover, contribute to differing mechanisms of virus-cell and cell-cell fusion. This
scenario is distinct from the case with RSV, for which proteolytic activation of F protein has
to take place in the macropinosome before capsid uncoating and release of the genome
(17). This step is also likely to be speciﬁc to mature particle entry during the vitally
important ﬁrst steps in human infection, since many of the late stages in MeV dissemina-
tion, particularly in the epithelia, rely on cell-cell contact and/or cell fusion (10). However,
entry in this context is via a separate receptor, nectin-4 (8, 32). Importantly, MeV spread
within the lymphatic system, in the early stages of disease, is SLAMF1 dependent, and this
entry pathway may contribute to the widespread infection seen in lymph nodes (32).
The morphological response of cells to MeV infection is characteristic of the global
membrane activation seen during classical macropinocytosis (23). This was supported
by the signiﬁcant uptake of extracellular ﬂuid upon infection, sensitivity to EIPA, and
the observation that incoming MeV particles associate with ﬂuorescent dextran mac-
ropinosomes (Fig. 9D). Other viruses, e.g., RSV and vaccinia virus, reported to enter cells
via macropinocytosis demonstrate similar phenotypes and are inhibited by these drugs
(17, 21, 33). We also show that MeV is sensitive to perturbation of myosin II-associated
blebbing through the speciﬁc inhibitor blebbistatin (Fig. 9B). However, we observed a
differing sensitivity when examining a role for proteins such as Rac1, Cdc42, and PAK-1.
These data are consistent with macropinocytosis not representing a single pathway but
rather reﬂecting an umbrella term for several endocytosis mechanisms for ﬂuid inter-
nalization with distinct, yet overlapping, phenotypes and mechanisms (34, 35).
Our studies show an integral role for SLAMF1 in MeV entry that most likely relates to a
physiological role for this protein. Although SLAMF1 can regulate bacterial phagocytic
killing, it seems unlikely that this pathway is involved in MeV entry, since SLAMF1/ cells
are phagocytically competent (4). Moreover, the global membrane activation and ﬂuid
uptake seen followingMeV infection are atypical of phagocytosis (23). Themembrane blebs
and ﬁlopodia formed are typical features of macropinocytosis and cellular motility required
for responding to changes in the extracellular environment (36). It was interesting to see
that MeV is reliant on the RhoA-ROCK-myosin II axis, a regulator of mechanotransduction
(25). It will be interesting to examine whether the SLAMF1 cytoplasmic tail interacts
with this axis and plays a role in immune cell migration. Recent ﬁndings that
SLAMF1 interacts with beclin-1, which recruits a class III phosphatidylinositol 3-kinase
that generates phosphatidylinositol-3-phosphate, support a role for this signaling
molecule in membrane rearrangement and cell motility (4). Since immune cells are
primary targets during MeV infection (6), it is possible that virus-induced SLAMF1-
mediated signaling may inﬂuence subsequent immune cell interactions (37) and may
contribute to the long-term immunosuppression associated with this infection.
MeV endocytosis appears to be reliant on the cell’s cortical actin cytoskeleton and
infection induced signiﬁcant changes in host cell morphology (Fig. 9B and C). Similar
cytoskeletal changes were reported following Kaposi’s sarcoma-associated herpesvirus
(KSHV), vaccinia virus, and African swine fever virus (ASFV) infections (21, 33, 38).
Signiﬁcantly, incoming MeV particles were found to associate with these cytoskeletal
rearrangements; however, it remains to be determined whether the viral genome uses
the cytoskeleton to trafﬁc through the cell or to establish sites for transcription. In this
context, it was interesting to observe rapid phosphorylation of the ERM proteins soon after
entry, sincemoesin has previously been debated to be aMeV entry factor (39). A future area
to investigate is the site of MeV internalization. While we observed colocalization of virus
particles with membranous blebs, it is unclear if their collapse leads to virus internalization
or whether the virus “surfs” on these structures to direct particles to speciﬁc sites for
internalization (40). A recent review on virus entry highlights the role of immunoglobulin-
like domains, similar to those in SLAMF1, to regulate pathogen entry (41). We speculate that
MeV binding to SLAMF1 may induce receptor clustering as observed for the vaccine strain
of MeV following the engagement of receptor CD46 (42), possibly explaining the extensive
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formation of ﬁlopodium-like structures we observed, although it should be noted that
wild-type MeV does not bind CD46. MeV internalization may induce intracellular signaling
via SLAMF1, and it will be interesting to examine whether receptor cross-linking is impor-
tant, as reported for MeV interaction with CD46 (42).
In summary, these ﬁndings highlight a new internalization pathway for MeV to enter
a host cell that is SLAMF1 dependent (Fig. 9). Given the ubiquitous usage of SLAMF1 as
an entry receptor for all morbilliviruses (16), we believe that these ﬁndings will have
wide-ranging impact for other members of this genus. Our observation that MeV
engagement of SLAMF1 induces gross morphological changes and collapse of the
cytoskeleton highlights a new physiological role for SLAMF1. This newly characterized
pathway for MeV entry may provide a distinct advantage to the virus in certain
immunological niches in vivo, i.e., during the establishment of infection in the respira-
tory tract or later in the draining lymph nodes of the head and neck. Research can now
focus on examining whether morbillivirus infection perturbs SLAMF1-dependent im-
mune function and explains virus-induced immunosuppression.
MATERIALS AND METHODS
Cell culture and viruses. Cells of the A549 (ATCC CCL-185) and HEK293T (ATCC CRL-11268G-1) lines
(from the ATCC) were engineered to express human SLAMF1 (43) and maintained in complete medium
with puromycin (1 g/ml; Sigma) at 37°C and 5% CO2. Parental A549 cells and HEK293T cells were grown
in complete medium without puromycin. Vero cells (ATCC CCL-81) engineered to overexpress human
SLAMF1 (Vero-SLAM [5]) were maintained in complete medium supplemented with Geneticin (0.4
mg/ml; Sigma). Epstein-Barr virus (EBV)-immortalized peripheral B lymphocytes (University of Birming-
ham cell collections) were cultured in complete medium. Recombinant MeV strain IC323 expressing the
enhanced green ﬂuorescent protein (EGFP) open reading frame (ORF) p()MV323EGFP was generated as
previously reported by Hashimoto et al. (44). After initial rescue, MeV stocks were produced in Vero-
SLAMF1 cells. After the development of substantial cytopathic effects, cells were freeze-thawed, and
supernatants were clariﬁed by centrifugation at 3,500 rpm for 30 min at 4°C, aliquoted, and stored at
80°C; this virus was used in experiments that did not require puriﬁed virus. The virus puriﬁcation
method was adapted from the method of Cathomen et al. (45). Vero-SLAMF1 cells, grown in eight T175
ﬂasks to a conﬂuence of approximately 40%, were infected with MeV (MOI, 0.1) in 8 ml of serum-free
Dulbecco modiﬁed Eagle medium (DMEM) plus 1% penicillin/streptomycin (P/S) for 1 h at 37°C. This
inoculum was then removed and replaced with 10 ml of complete medium. Three to 4 days later, ﬂasks
were vigorously shaken and supernatants were collected and clariﬁed as before. Supernatants were
layered onto a 20% sucrose cushion (wt/vol in Hanks’ balanced salt solution [HBSS] with 25 mM HEPES
NaOH [pH 7.4]) and centrifuged at 32,000 rpm for 3 h at 4°C in an SW32 Ti rotor (Beckman Coulter). The
resultant pellets were resuspended in 1 ml of HBSS-HEPES, pooled, layered onto a 30-45-60% stepped
sucrose gradient, and centrifuged at 35,000 rpm for 3 h at 4°C in an SW40 rotor (Beckman Coulter). Two
opalescent bands were visualized under polarized light: one at the 60-45% interface (lower band) and the
other below the 30-45% interface (upper band). The lower band was extracted using a needle and
dialyzed separately overnight using a 10-kDa-molecular-mass-cutoff membrane tubing against 1 liter of
HBSS-HEPES. Puriﬁed virus was then aliquoted, stored at 80°C, and titrated. The quality and purity of
virus preparations were analyzed before use by SDS-PAGE and silver staining to conﬁrm minimal cellular
contaminants, as well as separate SDS-PAGE and Western blot analysis to conﬁrm the presence of MeV
proteins. Of note, only virus from the lower band was used in experiments, since it had a higher virus
titer. Virus titers were calculated using the Reed-Muench method (46).
Plasmids, cell transfections, and pharmacological inhibitors. All plasmids used were transfected
using TransIT-X2 dynamic delivery system (Mirus Bio LLC). The following plasmids were received as gifts:
p8.91 and pCSFLW (Edward Wright (47); pEPS15-DN-RFP, pCav-1-DN-GFP, and pDyn2-DN-RFP (Joshua
Rappoport [48]); pRhoA DN, pRhoA CA, pRac1 DN, pRac1 CA, Cdc42 DN, and Cdc42 CA (Patrick Caswell
[49]); and, ﬁnally, pRLuc1-7 and pRLuc18-11 (Zene Matsuda [50]). Wild-type MeV Dublin strain (51) (a kind
gift from Paul Duprex, Boston University) H and F protein ORFs were cloned into pcDNA3.1 after reverse
transcriptase PCR (RT-PCR). The construct pDublin-HΔ24 encodes an MeV Dublin strain H truncated at the
N terminus by 24 amino acids. It was ampliﬁed from the MeV Dublin strain H ORF using the forward
primer 5=-AATGGATCCACCATGAACAGAGAACATCTTATGATT-3=, containing a BamHI restriction site, and
reverse primer 5=-AATTGATATCCTACTATCTGCGRTTGGTTCCAT-3=, containing an EcoRV restriction site.
The insert was digested and cloned into the BamHI/EcoRV restriction sites of pcDNA3.1. Similarly, the
construct Dublin FΔ30 encodes a truncated version of the MeV Dublin strain F protein lacking 30 amino
acids at the C terminus. The insert was ampliﬁed from MeV Dublin strain F ORF using the forward primer
5=-AATTGCTAGCACCATGGGTCTCAAGGCGAG-3= and the reverse primer 5=-AATTGATATCCTACTACGCCC
CCTGCAGCAACATATT-3=, containing the NheI and EcoRV restriction sites, respectively. The insert was
digested and cloned into the NheI/EcoRV restriction sites of pcDNA3.1.
To generate the two constructs encoding PAK-1, mRNA was extracted from HEK293T cells using the
GenElute mammalian total RNA miniprep kit (Sigma) according to manufacturer’s guidelines. A cDNA
library was generated from the extracted mRNA using Moloney murine leukemia virus reverse transcrip-
tase (M-MLV RT; Promega) and a sequence of 15 thymine bases as a primer. cDNA encoding PAK-1 was
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ampliﬁed by PCR using the forward primer 5=-AATTGGATCCACCATGTCAAATAACGGCCTAGACA-3=, con-
taining the BamHI restriction site (underlined), and the reverse primer 5=-AATTGCGGCCGCCTATTAGCT
GCAGCAATCAGTG-3=, containing the NotI restriction site (underlined). Digested cDNA was inserted into
pcDNA3.1, and the point mutation T423E was introduce by site-directed mutagenesis using the primer
5=-AGCAAACGGAGCGAGATGGTAGGAACC-3= and respective reverse complement. All plasmids were
sequenced prior to transfection. All pharmacological inhibitors—chloroquine, ()-blebbistatin, phorbol 12-
myristate 13-acetate (PMA), baﬁlomycin A1, 5-(N-ethyl-N-isopropyl)amiloride (EIPA), IPA-3, chlorpromazine
(CPZ; Sigma-Aldrich), cytochalasin D, jasplakinolide, paclitaxel (originally named taxol; Calbiochem Merck
Millipore), wiskostatin (Enzo Life Sciences), ML141, CK-666 (Tocris), and glycyl-H1152 (Cayman Chemical)—
were tested for cytotoxicity prior to use by using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay to assess cell viability. Concentrations that caused a reduction in cell viability of
more than 87% of the DMSO- or water-treated cells were not used.
Pseudotyped virus particle genesis. HEK293T cells were transfected with 3.5 g each of pDublin-
FΔ30 and pDublin-H Δ24 (encoding cytoplasmic tail truncations of MeV F protein and H) or 1 g of
pVSV-G, 1.5 g of p8.91 (coding for HIV-1 gag-pol), and 1 g of pCSFLW (luciferase reporter lentivirus
backbone). Supernatants containing viral pseudotypes (PPs) were collected 48 and 72 h later, pooled,
and clariﬁed by centrifugation at 2,500 rpm at 4°C for 30 min. A549-SLAMF1 cells were seeded in a
96-well dish at 5  104 per well. After 24 h, cells were pretreated with pharmacological inhibitors in fetal
bovine serum (FBS)-free DMEM at the desired concentrations for 30 min at 37°C, followed by the addition
of 100 l of solution containing PPs, and then incubated for 5 h. Alternatively, A549-SLAMF1 or
HEK293T-SLAMF1 cells were transfected with 1 g of the desired constructs in 6-well dishes, and 48 h
later, cells were transferred to 96-well plates. Cells were incubated with 100 l of PPs for 5 h. In all cases,
medium was replaced after 5 h, and following a further 72 h of incubation, lentiviral infection was
assessed by lysing cells and measuring luciferase activity using the luciferase assay system (Promega)
according to the guidelines of the manufacturer, on a Centro LB960 microplate luminometer (Berthold
Technologies).
Virus entry assay. A549-SLAMF1 cells were pretreated or posttreated, in relation to infection, with
pharmacological inhibitors of endocytic pathways. Pretreated cells were incubated with the drug for 30
min prior to addition of virus (MOI  1) and incubated for an additional 1 h at 37°C in the presence of
drug, while posttreated cells were inoculated for 1 h, washed, and incubated with drug for 37°C for 90
min. In both cases, cells were trypsinized to remove noninternalized virus and incubated for a further 24
h. Syncytia were counted under UV light, and whole-cell lysates were generated using Laemmli buffer
and analyzed by Western blotting. To assess sensitivity to trypsin, A549-SLAMF1 cells were incubated
with MeV (MOI  30) at 4°C for 1 h. The inoculum was removed and cells were washed in cold
phosphate-buffered saline (PBS) and incubated at 37°C for 0, 15, or 30 min. At these time points, cells
were either trypsinized or detached with 2 mM EDTA in PBS (untreated) for 7 min at 37°C, pelleted,
and analyzed by Western blotting. As a control, uninfected cells were treated in a similar way. To assess
fusion upon entry mediated by the virus, we used a dual split reporter containing the Renilla luciferase
gene (50). HEK293T-SLAMF1 cells were transfected with one part of the reporter, synchronously infected
with puriﬁed MeV (MOI, 30), washed, and incubated at 37°C for 0, 15, 30, or 60 min prior to coculturing
with HEK293T-SLAMF1 cells expressing the complementary part of the reporter. When testing the effect
of chlorpromazine, cells were incubated for 30 min with 5 g/ml prior to virus adsorption. The drug
treatment was maintained throughout the short time course of the experiment. At each time point, cells
were incubated for 2 h before luciferase activity was measured in a luminometer through the addition
of 2 g/ml of cell-permeative coelenterazine 400A (Biotium).
Flow cytometry. A549-SLAMF1 cells were either pre- or posttreated with 25 or 50 M EIPA for 30
min and infected for 1 h at 37°C with recombinant MeV (MOI 1) that expressed EGFP. After this period,
cells were trypsinized, replated onto 6-well dishes, and incubated at 37°C for 6.5 h. Cells were detached
using a 2 mM EDTA solution in PBS for 20 min, washed, and ﬁxed in 4% paraformaldehyde (PFA). Cells
were analyzed for EGFP ﬂuorescence by ﬂow cytometry (CyAn 642 TM ADP analyzer; Beckman Coulter).
Western blotting. All protein samples were generated using Laemmli buffer and reduced at 95°C for
5 min before analysis. Samples were resolved on 15% acrylamide gels, and blots were probed with
primary antibodies, incubated in 5% milk-Tris-buffered saline (TBS) overnight, washed in TBS-Tween 20
(0.05%), and incubated with secondary antibodies coupled with horseradish peroxidase. Membranes
were exposed to Clarity Western ECL substrate (Bio-Rad Laboratories) according to the manufacturer’s
guidelines and exposed to autoradiographic ﬁlm.
Phase-contrast and SEM. Serum-starved A549-SLAMF1 cells or B-lymphoblastoid cells were prechilled
on ice and MeV (MOI, 45) bound to the cells at 4°C for 1 h. Uninfected cells were treated with DMEM
plus 20% FBS. After 1 h, the inoculum was removed and cells were washed in ice-cold PBS before being
moved to 37°C for 10, 20, or 60 min. For phase-contrast microscopy, cells were ﬁxed with 4% PFA and
visualized by phase-contrast microscopy using an inverted UV microscope (Nikon Eclipse TE2000-5
microscope coupled with a Nikon HB-10101AF superhigh-pressure mercury lamp) equipped with a
Hamamatsu C472-95 digital camera). Ten micrographs for each condition were recorded, and the
percentage of cells presenting membrane blebs was determined in relation to the total cell count per
ﬁeld of view. For scanning electron microscopy (SEM), cells were ﬁxed overnight with 4% PFA and 2.5%
glutaraldehyde at 4°C. Fixed cells were washed in PBS, postﬁxed in 2% osmium tetroxide, dehydrated in
acetone, and critical-point dried for 2 h. Finally, cells were coated with a 3-nm layer of platinum and
visualized by SEM (JSM-7000F JEOL SEM; Oxford Instruments INCA EDS system). For quantiﬁcation of
blebbing and rufﬂing cells, 12 micrographs of each sample were blinded, randomized, and scored.
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Immunoﬂuorescence assays. Cells were plated onto glass coverslips and synchronously infected
with MeV at 4°C for 1 h with gentle rocking. As an uninfected control, cells were incubated with medium
containing 20% FBS. Cells were washed and incubated in PBS at 37°C for the desired times or, in the ﬂuid
uptake assay, incubated in PBS containing 0.25 mg/ml of dextran-Alexa Fluor 488 (molecular weight,
10,000; Molecular Probes 627; Life Technologies). Surface-bound dextran was bleached by incubating
with cold bleach buffer (10 mM sodium acetate, 50 mM NaCl [pH 5.5]) for 10 min before washing with
PBS. In all cases, cells were ﬁxed in 4% PFA for 10 min at room temperature, permeabilized with 0.1%
Triton X-100 in PBS for 10 min, and blocked with 1% bovine serum albumin (BSA)–PBS for 30 min at room
temperature. Cells were incubated with primary antibodies in 1% BSA at 4°C overnight, washed in PBS,
and incubated with secondary antibodies conjugated with Alexa Fluor dyes (Invitrogen) for 1 h at room
temperature. For staining of actin, ﬁxed cells were incubated with a solution of 0.5 g/ml of the
phalloidin conjugate tetramethylrhodamine B isocyanate (phalloidin-TRITC; Sigma-Aldrich) in PBS for 30
min at room temperature and washed in PBS. Slides were mounted using Hoechst 33342 in Mowiol
632 mounting medium (Merck Millipore). To visualize the cells, we used a Leiss LSM 510 Meta
confocal microscope, and further analysis was performed using ZEN software and ImageJ.
Antibodies. Anti-cytoplasmic tail of measles virus hemagglutinin and anti-measles virus nucleocap-
sid 505 were gifts from Roberto Cattaneo’s lab (45). Anti-glyceraldehyde-3-phosphate dehydrogenase,
anti-phospho-ezrin (Thr567)/radixin (Thr564)/moesin (Thr558) (41A3; monoclonal antibody [MAb]
5175), anti-ezrin/radixin/moesin (3142), anti-alpha-p21-acivated kinase, and anti-rabbit IgG1 coupled
with horseradish peroxidase were all purchased from Cell Signaling Technology.
Image analysis. To calculate total cell ﬂuorescence in the ﬂuid phase uptake experiment,
micrographs recorded at 488 nm were converted to 8-bit images. A total of 16 cells per sample were
individually selected, and area and mean ﬂuorescence intensity were calculated using ImageJ. For
each cell, 4 different regions were selected and the corresponding background mean ﬂuorescence was
subtracted from that cell intensity to generate corrected cell ﬂuorescence. The average area of
phalloidin-stained cells was calculated by bringing the background of individual micrographs to a level
of threshold (overﬂow) that enabled clear distinction of the cell’s edges and measurement of area (pixel
units). Confocal intensity proﬁles of dextran and MeV N-positive cells were obtained by calculating red
and green channels intensities across the indicated lines, using ZEN microscope and imaging software
(Zeiss 2.3, blue edition).
Statistical analysis. Statistical analysis was performed using GraphPad Prism 5 where groups of two
were analyzed using the unpaired two-tailed Student t test, unless otherwise stated. We considered a P
value lower than or equal to 0.05 as a minimum threshold for signiﬁcance.
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